株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CountryFocus:日本の医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

発行 GlobalData 商品コード 275366
出版日 ページ情報 英文 272 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
CountryFocus:日本の医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan
出版日: 2015年02月18日 ページ情報: 英文 272 Pages
概要

日本の医薬品市場は、2012年に891億米ドルの規模に達し、その後も年平均(CAGR)2%で成長し、2020年には1045億米ドルにまで拡大すると予想されています。また、同国の医療機器市場は、2012年には468億米ドル、2020年には739億米ドルの規模に達すると予想されています。

当レポートでは、日本の医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、日本経済・社会に関するマクロ的指標(医療インフラなど)といった情報を取りまとめて、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野
    • 主要企業
  • 医療機器市場
    • 市場概況
    • 上位5分野の概況
    • 診断市場
    • 主要企業
  • 市場促進要因と障壁
    • 促進要因
    • 課題

第4章 市場へのアクセス

  • 医療費償還・保険料支払者の状況
    • 医療制度の概要
    • 医療費償還過程
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 処方薬の価格動向
    • 薬価政策
  • 規制環境
    • 概要
    • 規制当局
    • 医薬品の発売認可過程
    • 医療機器の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出・輸入の認可
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 医療従事者
  • 医療費支出
    • 概要
    • 医療費支出の主な要素
    • 公共/民間部門のシェア
    • 医療関連の研究開発(R&D)支出額
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0077CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2008, Japan's pharmaceutical market was worth $64.2 billion. It is projected to reach $79.8 billion in 2020, increasing at a Compound Annual Growth Rate (CAGR) of 1.8%. The medical device market was valued at $37 billion and is projected to grow at a CAGR of 6.1% to $75 billion in 2020, owing to universal health coverage, government initiatives, and an accessible healthcare system.

In 2013, Japan's population was approximately 127.2 million, having declined at a negative CAGR of 0.02% from 2008. Its public healthcare expenditure accounted for 82.8% of total healthcare expenditure, and the government spent approximately $14 billion on pharmaceutical R&D.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Japan and includes -

  • An overview of the pharmaceutical and medical device markets, including market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analysis of the major players in the pharmaceutical market (Takeda, Otsuka, Pfizer, Astellas and Daiichi Sankyo) and medical device market (Hoya, Siemens Healthcare, Abbott, Medtronic and F. Hoffmann-La Roche)
  • A review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Japan's healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Japan's healthcare market
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in Japan's healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of the Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Imports and Exports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Major Therapeutic Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
    • 3.2.2. Overview of Top-Five Segments
    • 3.2.3. Diagnostics Market
    • 3.2.4. Major Players
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of the Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patients' Share of Healthcare Spending
    • 4.1.5. Prescription Drug Price Trend
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview
    • 4.2.2. Regulatory Agencies
    • 4.2.3. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.4. New Device Approval Process
    • 4.2.5. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.6. Licensing for Pharmaceutical Exports and Imports
    • 4.2.7. Intellectual Property Rights
    • 4.2.8. Clinical Trial Regulations
    • 4.2.9. Pharmaceutical Advertising Regulations
    • 4.2.10. Pharmacy Regulations
    • 4.2.11. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. General Government Structural Balance
    • 5.3.9. General Government Gross Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Share of Public and Private Sector
    • 5.6.4. Pharmaceutical and Healthcare R&D Expenditure
  • 5.7. Trade Associations
    • 5.7.1. Japan Pharmaceutical Manufacturers Association
    • 5.7.2. Federation of Pharmaceutical Manufacturers' Associations
    • 5.7.3. Japan Pharmaceutical Traders Association
    • 5.7.4. Japan Pharmaceutical Equipment and Machinery Association
    • 5.7.5. Japan Federation of Medical Devices Associations
    • 5.7.6. The Federation of Japan Pharmaceutical Wholesalers Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Japan, Revenue ($bn), 2008-2013
  • Table 2: Pharmaceutical Market, Japan, Revenue Forecast ($bn), 2014-2020
  • Table 3: Pharmaceutical Market, Japan, Exports and Imports ($bn), 2008-2013
  • Table 4: Pharmaceutical Market, Japan, Generics Market Share (%), 2008-2013
  • Table 5: Pharmaceutical Market, Japan, Biologics Production, 2012
  • Table 6: Pharmaceutical Market, Japan, Over-the-Counter Production, Revenue ($bn), 2008-2013
  • Table 7: Pharmaceutical Market, Japan, Major Therapeutic Areas, Pharmaceutical Production, 2012
  • Table 8: Pharmaceutical Market, Japan, Major Therapeutic Areas, Pharmaceutical Production (%), 2011-2012
  • Table 9: Pharmaceutical Market, Japan, Cardiovascular Agents, Segment Shares, 2012
  • Table 10: Pharmaceutical Market, Japan, Central Nervous System Agents, Segment Shares, 2012
  • Table 11: Pharmaceutical Market, Japan, Agents Affecting Metabolism, Segment Shares, 2012
  • Table 12: Pharmaceutical Market, Japan, Digestive Organ Agents, Segment Shares, 2012
  • Table 13: Pharmaceutical Market, Japan, Blood and Body-Fluid Agents, Segment Shares, 2012
  • Table 14: Pharmaceutical Market, Takeda, Global, Major Products, 2013
  • Table 15: Pharmaceutical Market, Takeda, Global, Late-Stage Pipeline, 2014
  • Table 16: Pharmaceutical Market, Otsuka, Global, Late-Stage Pipeline, 2014
  • Table 17: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 18: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014*
  • Table 19: Pharmaceutical Market, Astellas, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 20: Pharmaceutical Market, Astellas, Global, Late-Stage Pipeline, 2013
  • Table 21: Pharmaceutical Market, Daiichi Sankyo, Global, Late-Stage Pipeline, 2014
  • Table 22: Medical Device Market, Japan, Revenue ($bn), 2008-2013
  • Table 23: Medical Device Market, Japan, Revenue Forecast ($bn), 2014-2020
  • Table 24: Medical Device Market, Japan, Revenue by Segment, 2013
  • Table 25: Medical Device Market, Japan, Ophthalmic Devices Market, Revenue ($bn), 2008-2013
  • Table 26: Medical Device Market, Japan, Ophthalmic Devices Market, Sales Trends for Major Players, 2012
  • Table 27: Medical Device Market, Japan, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013
  • Table 28: Medical Device Market, Japan, In Vitro Diagnostics Market, Sales Trends for Major Players, 2012
  • Table 29: Medical Device Market, Japan, Cardiovascular Devices Market, Revenue ($bn), 2008-2013
  • Table 30: Medical Device Market, Japan, Cardiovascular Devices Market, Sales Trends for Major Players, 2012
  • Table 31: Medical Device Market, Japan, Healthcare IT Market, Revenue ($bn), 2008-2013
  • Table 32: Medical Device Market, Japan, Healthcare IT Market, Sales Trends for Major Players, 2012
  • Table 33: Medical Device Market, Japan, Nephrology and Urology Market, Revenue ($bn), 2008-2013
  • Table 34: Medical Device Market, Japan, Nephrology and Urology Market, Sales Trends for Major Players, 2012
  • Table 35: Medical Device Market, Japan, Diagnostics Market, Revenue ($bn), 2008-2013
  • Table 36: Medical Device Market, Japan, Diagnostics Market, Revenue Forecast ($bn), 2014-2020
  • Table 37: Medical Device Market, Japan, Diagnostics Market, Sales Trends for Major Players, 2012
  • Table 38: Medical Device Market, Abbott, Global, Major Products, 2014
  • Table 39: Medical Device Market, Abbott, Global, Late-Stage Pipeline, 2014
  • Table 40: Medical Device Market, Medtronic, Global, Major Products, 2013
  • Table 41: Medical Device Market, Roche, Global, Major Products, 2014
  • Table 42: Market Access, Japan, Types of Health Insurance, 2011
  • Table 43: Market Access, Japan, Out-of-Pocket Payments (% of Healthcare Expenditure), 2008-2013
  • Table 44: Market Access, Japan, Reduction in Average Price of Prescription Drugs (%), 2004-2014
  • Table 45: Market Access, Japan, Requirements for Applying Premiums for Drug Prices, 2014
  • Table 46: Market Access, Japan, Review Time for New Drugs, 2008-2012
  • Table 47: Economic Indicators, Japan, Gross Domestic Product per Capita ($), 2008-2013
  • Table 48: Economic Indicators, Japan, Gross Domestic Product per Capita Forecast ($), 2014-2020
  • Table 49: Economic Indicators, Japan, Gross Domestic Product Annual Growth (%), 2008-2013
  • Table 50: Economic Indicators, Japan, Gross Domestic Product Annual Growth Forecast (%), 2014-2020
  • Table 51: Economic Indicators, Japan, Gross National Income per Capita ($), 2008-2013
  • Table 52: Economic Indicators, Japan, Average Consumer Price Index, 2008-2013
  • Table 53: Economic Indicators, Japan, Average Consumer Price Index Forecast, 2014-2020
  • Table 54: Economic Indicators, Japan, Average Consumer Price Annual Change (%), 2008-2013
  • Table 55: Economic Indicators, Japan, Average Consumer Price Annual Change Forecast (%), 2014-2020
  • Table 56: Economic Indicators, Japan, Currency Exchange Rate ($/JPY), 2008-2013
  • Table 57: Economic Indicators, Japan, Foreign Direct Investment ($bn), 2008-2013
  • Table 58: Economic Indicators, Japan, Foreign Exchange Reserves ($bn), 2008-2013
  • Table 59: Economic Indicators, Japan, Imports of Goods and Services ($bn), 2008-2013
  • Table 60: Economic Indicators, Japan, Exports of Goods and Services ($bn), 2008-2013
  • Table 61: Economic Indicators, Japan, General Government Structural Balance ($bn), 2008-2013
  • Table 62: Economic Indicators, Japan, General Government Gross Debt (% of GDP), 2008-2013
  • Table 63: Economic Indicators, Japan, Major Industries, Output ($bn), 2011
  • Table 64: Demographics, Japan, Population (million), 2008-2013
  • Table 65: Demographics, Japan, Population Forecast (million), 2014-2020
  • Table 66: Demographics, Japan, Population, Urban-Rural Population Share (%), 2008-2013
  • Table 67: Demographics, Japan, Population, Urban-Rural Population Share Forecast (%), 2014-2020
  • Table 68: Demographics, Japan, Distribution by Age Group (%), 2008-2013
  • Table 69: Demographics, Japan, Distribution by Age Group Forecast (%), 2014-2020
  • Table 70: Demographics, Japan, Births (per 1,000 population), 2008-2013
  • Table 71: Demographics, Japan, Mortality (per 1,000 population), 2008-2013
  • Table 72: Demographics, Japan, Major Causes of Mortality (per 100,000 population), 2012
  • Table 73: Demographics, Japan, Mortality Rate of Children under Five (per 1,000 live births), 2008-2013
  • Table 74: Demographics, Japan, Immunization Rate (%), 2008-2013
  • Table 75: Demographics, Japan, Major Causes of Male Mortality (per 100,000 population), 2012
  • Table 76: Demographics, Japan, Major Causes of Female Mortality (per 100,000 population), 2012
  • Table 77: Demographics, Japan, Gender Ratio (M/F), 2008-2013
  • Table 78: Demographics, Japan, Life Expectancy at Birth (years), 2008-2013
  • Table 79: Demographics, Japan, Student Enrollment by Level of Education ('000), 2013
  • Table 80: Demographics, Japan, Unemployment Rate (%), 2008-2013
  • Table 81: Demographics, Japan, Unemployment Rate by Age and Gender, 2013
  • Table 82: Demographics, Japan, Major Diseases, Inpatients (per 1,000 population), 2011
  • Table 83: Demographics, Japan, Major Diseases, Outpatients (per 1,000 population), 2011
  • Table 84: Demographics, Japan, Disability-Adjusted Life Years (per 100,000 population), 2004
  • Table 85: Healthcare Infrastructure, Japan, Hospitals, 2008-2013
  • Table 86: Healthcare Infrastructure, Japan, Hospitals by Services, 2008-2013
  • Table 87: Healthcare Infrastructure, Japan, Clinics by Type, 2008-2013
  • Table 88: Healthcare Infrastructure, Japan, Medical Clinics, 2008-2013
  • Table 89: Healthcare Infrastructure, Japan, Hospital Beds ('000), 2008-2013
  • Table 90: Healthcare Infrastructure, Japan, Hospitals by Bed Size, 2008-2013
  • Table 91: Healthcare Infrastructure, Japan, Diagnostic units (per million population), 2008-2013
  • Table 92: Healthcare Infrastructure, Japan, Hospital Beds (per 100,000 population), 2008-2013
  • Table 93: Healthcare Infrastructure, Japan, Physicians (per 1,000 population), 2008-2013
  • Table 94: Healthcare Infrastructure, Global Comparison, Environment-Attributable Deaths (per 100,000 population), 2004
  • Table 95: Healthcare Infrastructure, Japan, CO2 Emissions (million metric tons), 2008-2013
  • Table 96: Healthcare Infrastructure, Japan, CO2 Emissions by Sector (%), 2012
  • Table 97: Healthcare Infrastructure, Japan, PM10 Emissions (µg/m3), 2008-2013
  • Table 98: Healthcare Infrastructure, Japan, Municipal Waste (million tons), 2008-2013
  • Table 99: Healthcare Infrastructure, Japan, Pharmacist (per 100,000 population), 2008-2013
  • Table 100: Healthcare Infrastructure, Japan, Dentists (per 100,000 population), 2008-2013
  • Table 101: Healthcare Infrastructure, Japan, Nurses and Assistant Nurses (per 100,000 population), 2008-2013
  • Table 102: Healthcare Expenditure, Japan, Gross Domestic Product as Percentage of Healthcare Expenditure (%), 2008-2013
  • Table 103: Healthcare Expenditure, Japan, Share of Major Components (%), 2009
  • Table 104: Healthcare Expenditure, Japan, Healthcare Expenditure on Elderly ($bn), 2008-2013
  • Table 105: Healthcare Expenditure, Japan, Research and Development Expenditure % 2008-2013
  • Table 106: Healthcare Expenditure, Japan, Public-Private Share (%), 2008-2013
  • Table 107: Healthcare Expenditure, Japan, Research and Development Expenditure ($bn), 2008-2013
  • Table 108: Trade Fairs, Japan, Major Healthcare Trade Fairs, 2015

List of Figures

  • Figure 1: Pharmaceutical Market, Japan, Revenue ($bn), 2008-2013
  • Figure 2: Pharmaceutical Market, Japan, Revenue Forecast ($bn), 2014-2020
  • Figure 3: Pharmaceutical Market, Japan, Imports and Exports ($bn), 2008-2013
  • Figure 4: Pharmaceutical Market, Japan, Distribution Channel, 2014
  • Figure 5: Pharmaceutical Market, Japan, Generics Market Share (%), 2008-2013
  • Figure 6: Pharmaceutical Market, Japan, Biologics Market Share (%), 2012
  • Figure 7: Pharmaceutical Market, Japan, Over-the-Counter Production, Revenue ($bn), 2008-2013
  • Figure 8: Pharmaceutical Market, Japan, Major Therapeutic Areas, Pharmaceutical Production (%), 2012
  • Figure 9: Pharmaceutical Market, Japan, Major Therapeutic Areas, Pharmaceutical Production (%), 2011-2012
  • Figure 10: Pharmaceutical Market, Japan, Cardiovascular Agents, Segment Shares (%), 2012
  • Figure 11: Pharmaceutical Market, Japan, Central Nervous System Agents, Segment Shares (%), 2012
  • Figure 12: Pharmaceutical Market, Japan, Agents Affecting Metabolism, Segment Shares (%), 2012
  • Figure 13: Pharmaceutical Market, Japan, Digestive Organ Agents, Segment Shares (%), 2012
  • Figure 14: Pharmaceutical Market, Japan, Blood and Body-Fluid Agents, Segment Shares (%), 2012
  • Figure 15: Medical Device Market, Japan, Revenue ($bn), 2008-2013
  • Figure 16: Medical Device Market, Japan, Revenue Forecast ($bn), 2014-2020
  • Figure 17: Medical Device Market, Japan, Revenue by Segment ($bn), 2013
  • Figure 18: Medical Device Market, Japan, Ophthalmic Devices Market, Revenue ($bn), 2008-2013
  • Figure 19: Medical Device Market, Japan, Ophthalmic Devices Market, Sales Trends for Major Players ($m), 2008-2012
  • Figure 20: Medical Device Market, Japan, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013
  • Figure 21: Medical Device Market, Japan, In Vitro Diagnostics Market, Sales Trends for Major Players ($m), 2008-2012
  • Figure 22: Medical Device Market, Japan, Cardiovascular Devices Market, Revenue ($bn), 2008-2013
  • Figure 23: Medical Device Market, Japan, Cardiovascular Devices Market, Sales Trends for Major Players ($m), 2008-2012
  • Figure 24: Medical Device Market, Japan, Healthcare IT Market, Revenue ($bn), 2008-2013
  • Figure 25: Medical Device Market, Japan, Healthcare IT Market, Sales Trends for Major Players ($m), 2008-2012
  • Figure 26: Medical Device Market, Japan, Nephrology and Urology Market, Revenue ($bn), 2008-2013
  • Figure 27: Medical Device Market, Japan, Nephrology and Urology Market, Sales Trends for Major Players ($m), 2008-2012
  • Figure 28: Medical Device Market, Japan, Diagnostics Market, Revenue ($bn), 2008-2013
  • Figure 29: Medical Device Market, Japan, Diagnostics Market, Revenue Forecast ($bn), 2014-2020
  • Figure 30: Medical Device Market, Japan, Diagnostics Market, Revenue Forecast ($m), 2012
  • Figure 31: Healthcare Market, Japan, Drivers and Barriers, 2014
  • Figure 32: Market Access, Japan, MHLW, Organizational Structure, 2014
  • Figure 33: Market Access, Japan, Reimbursement Pricing for New Drugs, 2014
  • Figure 34: Market Access, Japan, Health Insurance System, 2014
  • Figure 35: Market Access, Japan, Health Insurers, Market Share (%), 2011
  • Figure 36: Market Access, Japan, Out-of-Pocket Payments (% of Healthcare Expenditure), 2008-2013
  • Figure 37: Market Access, Japan, Reduction in Average Price of Prescription Drugs (%), 2004-2014
  • Figure 38: Market Access, Japan, Organizational Structure of PMDA and PFSB, 2014
  • Figure 39: Market Access, Japan, New Drug Development and Approval Process, 2014
  • Figure 40: Market Access, Japan, Approval Review Process, 2014
  • Figure 41: Market Access, Japan, Standard Review Timeline for New Drug, 2014
  • Figure 42: Market Access, Japan, Medical Device Classification, 2014
  • Figure 43: Market Access, Japan, Medical Device Approval Process, 2007
  • Figure 44: Market Access, Japan, Highly Controlled Medical Devices Approval Process, 2007
  • Figure 45: Market Access, Japan, Licensing Process for Drug Manufacture, Domestic Manufacturers, 2014
  • Figure 46: Market Access, Japan, Licensing Process for Manufacturing of Drugs, Overseas Manufacturers, 2014
  • Figure 47: Market Access, Japan, Patent Approval Process, 2014
  • Figure 48: Market Access, Japan, Patent Right Extension Process, 2014
  • Figure 49: Market Access, Japan, Trademark Approval Process, 2014
  • Figure 50: Market Access, Japan, Clinical Trial Regulation Process, 2014
  • Figure 51: Economic Indicators, Japan, Gross Domestic Product per Capita ($), 2008-2013
  • Figure 52: Economic Indicators, Japan, Gross Domestic Product per Capita Forecast ($), 2014-2020
  • Figure 53: Economic Indicators, Japan, Gross Domestic Product Annual Growth (%), 2008-2013
  • Figure 54: Economic Indicators, Japan, Gross Domestic Product Annual Growth Forecast (%), 2014-2020
  • Figure 55: Economic Indicators, Japan, Gross National Income per Capita ($), 2008-2013
  • Figure 56: Economic Indicators, Japan, Average Consumer Price Index, 2008-2013
  • Figure 57: Economic Indicators, Japan, Average Consumer Price Index Forecast, 2014-2020
  • Figure 58: Economic Indicators, Japan, Average Consumer Price Annual Change (%), 2008-2013
  • Figure 59: Economic Indicators, Japan, Average Consumer Price Annual Change Forecast (%), 2014-2020
  • Figure 60: Economic Indicators, Japan, Currency Exchange Rate ($/JPY), 2008-2013
  • Figure 61: Economic Indicators, Japan, Foreign Direct Investment ($bn), 2008-2013
  • Figure 62: Economic Indicators, Japan, Foreign Exchange Reserves ($bn), 2008-2013
  • Figure 63: Economic Indicators, Japan, Imports of Goods and Services ($bn), 2008-2013
  • Figure 64: Economic Indicators, Japan, Exports of Goods and Services ($bn), 2008-2013
  • Figure 65: Economic Indicators, Japan, General Government Structural Balance ($bn), 2008-2013
  • Figure 66: Economic Indicators, Japan, General Government Gross Debt (% of GDP), 2008-2013
  • Figure 67: Economic Indicators, Japan, Major Industries, Output ($bn), 2011
  • Figure 68: Demographics, Japan, Population (million), 2008-2013
  • Figure 69: Demographics, Japan, Population Forecast (million), 2014-2020
  • Figure 70: Demographics, Japan, Population, Urban-Rural Population Share (%), 2008-2013
  • Figure 71: Demographics, Japan, Population, Urban-Rural Population Share Forecast (%), 2014-2020
  • Figure 72: Demographics, Japan, Distribution by Age Group (%), 2008-2013
  • Figure 73: Demographics, Japan, Distribution by Age Group Forecast (%), 2014-2020
  • Figure 74: Demographics, Japan, Births (per 1,000 population), 2008-2013
  • Figure 75: Demographics, Japan, Mortality (per 1,000 population), 2008-2013
  • Figure 76: Demographics, Japan, Major Causes of Mortality (per 100,000 population), 2012
  • Figure 77: Demographics, Japan, Mortality Rate of Children under Five (per 1,000 live births), 2008-2013
  • Figure 78: Demographics, Japan, Immunization Rate (%), 2008-2013
  • Figure 79: Demographics, Japan, Major Causes of Male Mortality (per 100,000 population), 2012
  • Figure 80: Demographics, Japan, Major Causes of Female Mortality (per 100,000 population), 2012
  • Figure 81: Demographics, Japan, Gender Ratio (M/F), 2008-2013
  • Figure 82: Demographics, Japan, Life Expectancy at Birth (years), 2008-2013
  • Figure 83: Demographics, Japan, Student Enrollment by Level of Education ('000), 2013
  • Figure 84: Demographics, Japan, Unemployment Rate (%), 2008-2013
  • Figure 85: Demographics, Japan, Unemployment Rate by Age and Gender (%), 2013
  • Figure 86: Demographics, Japan, Major Diseases, Inpatients (per 1,000 population), 2011
  • Figure 87: Demographics, Japan, Major Diseases, Outpatients (per 1,000 population), 2011
  • Figure 88: Demographics, Japan, Disability-Adjusted Life Years (per 100,000 population), 2004
  • Figure 89: Healthcare Infrastructure, Japan, Hospitals, 2008-2013
  • Figure 90: Healthcare Infrastructure, Japan, Hospitals by Services, 2008-2013
  • Figure 91: Healthcare Infrastructure, Japan, Clinics by Type, 2008-2013
  • Figure 92: Healthcare Infrastructure, Japan, Medical Clinics, 2008-2013
  • Figure 93: Healthcare Infrastructure, Japan, Hospital Beds ('000), 2008-2013
  • Figure 94: Healthcare Infrastructure, Japan, Hospitals by Bed Size, 2008-2013
  • Figure 95: Healthcare Infrastructure, Japan, Diagnostic Units (per million population), 2008-2013
  • Figure 96: Healthcare Infrastructure, Japan, Hospital Beds (per 100,000 population), 2008-2013
  • Figure 97: Healthcare Infrastructure, Japan, Physicians (per 1,000 population), 2008-2013
  • Figure 98: Healthcare Infrastructure, Global Comparison, Environment-Attributable Deaths (per 100,000 population), 2004
  • Figure 99: Healthcare Infrastructure, Japan, CO2 Emissions (million metric tons), 2008-2013
  • Figure 100: Healthcare Infrastructure, Japan, CO2 Emissions by Sector (%), 2012
  • Figure 101: Healthcare Infrastructure, Japan, PM10 Emissions (µg/m3), 2008-2013
  • Figure 102: Healthcare Infrastructure, Japan, Municipal Waste (million tons), 2008-2013
  • Figure 103: Healthcare Infrastructure, Japan, Pharmacists (per 100,000 population), 2008-2013
  • Figure 104: Healthcare Infrastructure, Japan, Dentists (per 100,000 population), 2008-2013
  • Figure 105: Healthcare Infrastructure, Japan, Nurses and Assistant Nurses (per 100,000 population), 2008-2013
  • Figure 106: Healthcare Expenditure, Japan, Gross Domestic Product as Percentage of Healthcare Expenditure (%), 2008-2013
  • Figure 107: Healthcare Expenditure, Japan, Share of Major Components (%), 2009
  • Figure 108: Healthcare Expenditure, Japan, Healthcare Expenditure on Elderly ($bn), 2008-2013
  • Figure 109: Healthcare Expenditure, Japan, Pharmaceutical Research and Development Expenditure (% of total healthcare expenditure), 2008-2013
  • Figure 110: Healthcare Expenditure, Japan, Public-Private Share (%), 2008-2013
  • Figure 111: Healthcare Expenditure, Japan, Research and Development Expenditure ($bn), 2008-2013
  • Figure 112: Healthcare Market, Japan, Opportunities and Challenges, 2014
Back to Top